Details
Stereochemistry | RACEMIC |
Molecular Formula | C23H21NO4 |
Molecular Weight | 375.4171 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(NC1=CC=C(C=C1)C(O)=O)C(=O)C2=CC=C(C=C2)C3=CC=CC=C3
InChI
InChIKey=BPOMPTVRBWXZBY-UHFFFAOYSA-N
InChI=1S/C23H21NO4/c1-2-28-22(24-20-14-12-19(13-15-20)23(26)27)21(25)18-10-8-17(9-11-18)16-6-4-3-5-7-16/h3-15,22,24H,2H2,1H3,(H,26,27)
Xenazoic acid, an antiviral agent, was introduced in the early 1960s. Xenazoic acid might be of value in reducing the severity of meals infection if given early enough. Its use was associated with hepatic toxicity, which resulted in its withdrawal from the market in at least two countries (Belgium and France) in 1965. WHO has no information to suggest that xenazoic acid remains commercially available.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14021836
Single daily dose of 500 mg
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C281
Created by
admin on Sat Dec 16 17:43:51 GMT 2023 , Edited by admin on Sat Dec 16 17:43:51 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
58991
Created by
admin on Sat Dec 16 17:43:51 GMT 2023 , Edited by admin on Sat Dec 16 17:43:51 GMT 2023
|
PRIMARY | |||
|
CHEMBL1909289
Created by
admin on Sat Dec 16 17:43:51 GMT 2023 , Edited by admin on Sat Dec 16 17:43:51 GMT 2023
|
PRIMARY | |||
|
DTXSID10862575
Created by
admin on Sat Dec 16 17:43:51 GMT 2023 , Edited by admin on Sat Dec 16 17:43:51 GMT 2023
|
PRIMARY | |||
|
1174-11-4
Created by
admin on Sat Dec 16 17:43:51 GMT 2023 , Edited by admin on Sat Dec 16 17:43:51 GMT 2023
|
PRIMARY | |||
|
C66662
Created by
admin on Sat Dec 16 17:43:51 GMT 2023 , Edited by admin on Sat Dec 16 17:43:51 GMT 2023
|
PRIMARY | |||
|
43842
Created by
admin on Sat Dec 16 17:43:51 GMT 2023 , Edited by admin on Sat Dec 16 17:43:51 GMT 2023
|
PRIMARY | |||
|
SUB00101MIG
Created by
admin on Sat Dec 16 17:43:51 GMT 2023 , Edited by admin on Sat Dec 16 17:43:51 GMT 2023
|
PRIMARY | |||
|
100000079353
Created by
admin on Sat Dec 16 17:43:51 GMT 2023 , Edited by admin on Sat Dec 16 17:43:51 GMT 2023
|
PRIMARY | |||
|
1019
Created by
admin on Sat Dec 16 17:43:51 GMT 2023 , Edited by admin on Sat Dec 16 17:43:51 GMT 2023
|
PRIMARY | |||
|
59182
Created by
admin on Sat Dec 16 17:43:51 GMT 2023 , Edited by admin on Sat Dec 16 17:43:51 GMT 2023
|
PRIMARY | |||
|
KDU8VH09O8
Created by
admin on Sat Dec 16 17:43:51 GMT 2023 , Edited by admin on Sat Dec 16 17:43:51 GMT 2023
|
PRIMARY | |||
|
239062
Created by
admin on Sat Dec 16 17:43:51 GMT 2023 , Edited by admin on Sat Dec 16 17:43:51 GMT 2023
|
PRIMARY | |||
|
m532
Created by
admin on Sat Dec 16 17:43:51 GMT 2023 , Edited by admin on Sat Dec 16 17:43:51 GMT 2023
|
PRIMARY | Merck Index |
ACTIVE MOIETY